Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals shares soared 23.91 percent on volume of over 22 million shares traded Thursday to close at $8.24 a share. The company announced that they reported positive results from a Phasse III study of their Parkinson’s drug, pimavanserin, at the American Academy of Neurology Annual Meeting.
Going forward ... (see research report)
Subscribe to News Feeds